(Q74450227)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Immune responses to all ErbB family receptors detectable in serum of cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Bei R

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Masuelli L

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Moriconi E

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Visco V

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Moretti A

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Kraus MH

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Muraro R

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

1267-1275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10022808%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1202442

10 November 2019

exact match

0 references

cites work

Growth factors and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Modulation of mouse preimplantation development by epidermal growth factor receptor antibodies, antisense RNA, and deoxyoligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

CH Isotype 'Switching' During Normal B-Lymphocyte Development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Isolation of human anti-c-erbB-2 Fabs from a lymph node-derived phage display library

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

The biology of erbB-2/neu/HER-2 and its role in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Serum p53 antibodies as early markers of lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Immunohistochemical evidence of immune responses to tumor-associated antigens in lymph nodes of colon carcinoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Induction of anti-self-immunity to cure cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Oncogene products represent potential targets of tumor vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Receptor protein-tyrosine kinases and their signal transduction pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Induction of antigen-specific isotype switching by in vitro immunization of human naive B lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021

Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202442

7 January 2021